Bristol-Myers Launches Internal Review of Sales Practices - TheStreet

Bristol-Myers Launches Internal Review of Sales Practices

The company says it has initiated a probe of some of its sales and marketing practices.
Author:
Publish date:

Bristol-Myers Squibb

(BMY) - Get Report

said Tuesday that it has launched an internal review of some of its sales and marketing practices.

The company said in a press release that its review "focuses on whether these practices comply with the provisions of applicable 'antikickback' laws."

The company added, "The internal review also includes a review of the company's compliance with 'best price' requirements under the Medicaid program, and seeks to determine whether Medicaid rebates and pricing under certain other U.S. governmental programs which reference the Medicaid rebate program have been appropriate."

Bristol-Myers Squibb said it is "committed to compliance of its sales and marketing practices with all applicable requirements."